Cargando…

Apoptosis: A Target for Anticancer Therapy

Apoptosis, the cell’s natural mechanism for death, is a promising target for anticancer therapy. Both the intrinsic and extrinsic pathways use caspases to carry out apoptosis through the cleavage of hundreds of proteins. In cancer, the apoptotic pathway is typically inhibited through a wide variety...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfeffer, Claire M., Singh, Amareshwar T. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855670/
https://www.ncbi.nlm.nih.gov/pubmed/29393886
http://dx.doi.org/10.3390/ijms19020448
_version_ 1783307151225126912
author Pfeffer, Claire M.
Singh, Amareshwar T. K.
author_facet Pfeffer, Claire M.
Singh, Amareshwar T. K.
author_sort Pfeffer, Claire M.
collection PubMed
description Apoptosis, the cell’s natural mechanism for death, is a promising target for anticancer therapy. Both the intrinsic and extrinsic pathways use caspases to carry out apoptosis through the cleavage of hundreds of proteins. In cancer, the apoptotic pathway is typically inhibited through a wide variety of means including overexpression of antiapoptotic proteins and under-expression of proapoptotic proteins. Many of these changes cause intrinsic resistance to the most common anticancer therapy, chemotherapy. Promising new anticancer therapies are plant-derived compounds that exhibit anticancer activity through activating the apoptotic pathway.
format Online
Article
Text
id pubmed-5855670
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-58556702018-03-20 Apoptosis: A Target for Anticancer Therapy Pfeffer, Claire M. Singh, Amareshwar T. K. Int J Mol Sci Review Apoptosis, the cell’s natural mechanism for death, is a promising target for anticancer therapy. Both the intrinsic and extrinsic pathways use caspases to carry out apoptosis through the cleavage of hundreds of proteins. In cancer, the apoptotic pathway is typically inhibited through a wide variety of means including overexpression of antiapoptotic proteins and under-expression of proapoptotic proteins. Many of these changes cause intrinsic resistance to the most common anticancer therapy, chemotherapy. Promising new anticancer therapies are plant-derived compounds that exhibit anticancer activity through activating the apoptotic pathway. MDPI 2018-02-02 /pmc/articles/PMC5855670/ /pubmed/29393886 http://dx.doi.org/10.3390/ijms19020448 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Pfeffer, Claire M.
Singh, Amareshwar T. K.
Apoptosis: A Target for Anticancer Therapy
title Apoptosis: A Target for Anticancer Therapy
title_full Apoptosis: A Target for Anticancer Therapy
title_fullStr Apoptosis: A Target for Anticancer Therapy
title_full_unstemmed Apoptosis: A Target for Anticancer Therapy
title_short Apoptosis: A Target for Anticancer Therapy
title_sort apoptosis: a target for anticancer therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855670/
https://www.ncbi.nlm.nih.gov/pubmed/29393886
http://dx.doi.org/10.3390/ijms19020448
work_keys_str_mv AT pfefferclairem apoptosisatargetforanticancertherapy
AT singhamareshwartk apoptosisatargetforanticancertherapy